Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.76131 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.75077 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.75163 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.67204 | 32 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.71406 | 34 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.84974 | 34 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.78857 | 32 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.73229 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.73308 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.72721 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.7335 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.70652 | 32 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.75019 | 33 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.74014 | 33 |